Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Dec 01, 2009 (Vol. 29, No. 21)

RxList

URL:www.rxlist.com/script/main/hp.asp
  • Site layout and organization, detailed information
  • None

Nowadays, you can’t seem to avoid pharmaceutical advertising. During your favorite evening television show, you’re bound to see commercials for medical remedies to treat high cholesterol, depression, or other afflictions. If you find yourself having a difficult time keeping them all straight—or you’re curious to learn more about other drugs that aren’t found on primetime—then make an appointment with RxList. RxList is a comprehensive online drug index that provides a great deal of information about each entry. We’re not just talking about superficial details like name and function—here you’ll find chemical structures, biological mechanisms of action, dosage recommendations, and other information. There is a great deal of information beyond the medical and scientific terminology such as the slideshow series that covers topics as multifaceted as cosmetic surgery and black widow spider bites.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »